找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Gene Therapy; David T. Curiel,Joanne T. Douglas Book 2005 Humana Press 2005 cancer treatment.clinical trial.gene therapy.gene trans

[復(fù)制鏈接]
51#
發(fā)表于 2025-3-30 11:08:49 | 只看該作者
52#
發(fā)表于 2025-3-30 13:50:15 | 只看該作者
53#
發(fā)表于 2025-3-30 18:49:27 | 只看該作者
A. Bonso,A. Rossillo,R. Valente,A. Ravieleto the bedside. Between 1994 and the end of 2002, more than 25 clinical trials for TSG replacement therapy were initiated, and results indicated a promising future for TSG in the management of cancer.
54#
發(fā)表于 2025-3-30 21:28:27 | 只看該作者
New Advances in Histamine Researchnuclear (sn)RNAs as a ribozyme in complex with the premessenger RNA (pre-mRNA) to catalyze pre-mRNA splicing has also been proposed .. It is highly likely that additional RNA catalytic motifs and new roles for RNA-mediated catalysis will also be found as more is learned about the genomes of a variet
55#
發(fā)表于 2025-3-31 02:21:02 | 只看該作者
Book 2005cancer genes and gene delivery methods currently available for cancer gene therapy, including the transfer of genetic material into the cancer cells, stimulation of the immune system to recognize and eliminate cancer cells, and the targeting of the nonmalignant stromal cells that support their growt
56#
發(fā)表于 2025-3-31 06:57:48 | 只看該作者
57#
發(fā)表于 2025-3-31 11:14:32 | 只看該作者
58#
發(fā)表于 2025-3-31 14:09:43 | 只看該作者
59#
發(fā)表于 2025-3-31 20:06:07 | 只看該作者
https://doi.org/10.1007/978-88-470-2087-0 technologies in this field. For the purpose of this chapter, we use . to refer to the classical antisense approach. Other chapters in this book provide further information and discussions on ribozyme and aptamer approaches (. Chapter 5).
60#
發(fā)表于 2025-4-1 00:57:35 | 只看該作者
Antiphospholipid Syndrome Risk Evaluationnatives aimed at enhancing the selectivity of cancer chemotherapy for solid tumors rely on targeting cancer cells with chemoimmunoconjugates, antibody-directed enzyme prodrug therapy (ADEPT) ., or gene-directed enzyme prodrug therapy (GDEPT) ..
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 07:21
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
政和县| 黔西| 东明县| 图木舒克市| 鸡东县| 沧州市| 滁州市| 剑河县| 湘潭市| 江城| 大洼县| 巴东县| 华亭县| 大石桥市| 长兴县| 宁国市| 灌阳县| 牟定县| 陆良县| 营山县| 揭阳市| 饶平县| 吉安市| 灌云县| 河北区| 白沙| 越西县| 从化市| 绥滨县| 高雄市| 德格县| 乌拉特中旗| 琼结县| 海阳市| 察隅县| 津南区| 通化市| 潮安县| 合江县| 科技| 正蓝旗|